Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption

Wyl, Viktor vonViktor vonWylGianella, SaraSaraGianellaFischer, MarekMarekFischerNiederoest, BarbaraBarbaraNiederoestKuster, HerbertHerbertKusterBattegay, ManuelManuelBattegayBernasconi, EnosEnosBernasconiCavassini, MatthiasMatthiasCavassiniRauch, AndriAndriRauch0000-0001-5297-6062Hirschel, BernardBernardHirschelVernazza, PietroPietroVernazzaWeber, RainerRainerWeberJoos, BedaBedaJoosGünthard, Huldrych FHuldrych FGünthardSwiss HIV Cohort Study-SHCS2024-10-112024-10-112011https://boris-portal.unibe.ch/handle/20.500.12422/78690Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated.enEarly antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruptionarticle10.7892/boris.82642210289800029755530002310.1371/journal.pone.0027463